Avicanna Welcomes Initial U.S. Rescheduling of Medical Cannabis & Provides Scientific Update
The proposed rescheduling of cannabis to Schedule III represents a regulatory milestone that could unlock rigorous clinical research previously restricted under Schedule I classification. This change would enable pharmaceutical-grade development pathways…
Federal Cannabis Reform in Motion: What Businesses Need to Know | Ice Miller – JDSupra
Federal cannabis reform medical implications extend beyond policy headlines to real clinical practice considerations. Healthcare providers and patients must navigate evolving regulations while maintaining focus on evidence-based medical cannabis care.…
Proposed Rule to Establish Cannabis Research Infrastructure in Missouri
The 2026 cannabis research infrastructure proposal in Missouri aims to establish dedicated marijuana research facilities. This development could enhance clinical research and regulatory oversight. It represents a critical step toward advancing medical…
Griffith University’s new-look CBD campus unveiled – Newsreel
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Medical EducationResearch…
Forest Service to Close 57 Research Stations, Including 6 in California – SFGATE
The forest service research stations closure affects 57 facilities, including 6 in California. This change impacts environmental research infrastructure broadly. The forest service research stations closure does not directly relate to cannabis medicine…
CU Boulder and CSU Collaborate to Share Cannabis Research Facilities
Academic research partnerships cannabis between CU Boulder and CSU are set to accelerate cannabis research by pooling resources and expertise. This collaboration addresses long-standing infrastructure gaps in cannabis clinical research. Such partnerships…
Blood Donor Biobank Pipeline to Collect Genome-Based Samples for Research
The blood donor biobank pipeline is a groundbreaking infrastructure for collecting genome-based samples. This pipeline supports pharmacogenomics cannabis research by providing diverse genetic data. It paves the way for personalized cannabis medicine…
